Latest Market Data
Hang Seng Index
25,667.18
+129.11 (+0.51%)
HSCEI
9,257.62
+16.42 (+0.18%)
Hang Seng TECH Index
5,743.00
-2.74 (-0.05%)
Hang Seng HKEX Stock Connect China Enterprises Index
4,146.58
+8.24 (+0.20%)
MSCI China A 50 Connect Index
2,226.60
+9.82 (+0.44%)
HSI Volatility Index
22.93
-0.35 (-1.50%)
CSI 300 Index
4,149.04
+29.27 (+0.71%)
CES China120 Index
6,869.28
+8.61 (+0.13%)
USD/CNH Spot
7.1488
-0.0025 (-0.03%)
USD/INR Spot
86.3600
-0.0100 (-0.01%)
HKEX Bitcoin Reference Index
118,668.04
+197.36 (+0.17%)
HKEX Ether Reference Index
3,625.62
+31.29 (+0.87%)
CNH Gold Futures – Spot Price Index
-
- (-)
USD Gold Futures – Spot Price Index
-
- (-)
Refresh
Market Turnover
-






-
-
|
|
|
|
|
|
-
-
-
Loading

CUTIA THERAPEUTICS - B (2487)

CUTIA-B (2487)

HK$9.040

-0.120 (-1.31%)

Prev. Close is the most recent non-zero closing value or settlement price.PREV. CLOSE
HK$9.160
Open price is the first traded price of the day. The opening price is reported after 09:20:00 HKT.OPEN
HK$9.160
TURNOVER
HK$6.61M
VOLUME
742.40K
MKT CAP
HK$2.88B
LOT SIZE
200
BID
HK$9.040
ASK
HK$9.060
EPS
-
P/E
-
DIV YIELD
-
INTRA-DAY 52W
High HK$9.160 HK$18.260
Low HK$8.720 HK$3.640
Information is available after the market opens and is delayed by at least 15 minutes.
Updated: 24 Jul 2025 16:08 HKT
  • 1 D
  • 1 M
  • 3 M
  • 6 M
  • YTD
  • 1 Y
  • 2 Y
  • 5 Y
  • 10 Y
1min
5min
15min
Hourly
Created with Highstock 6.2.08.4008.6408.8809.1209.360030K60K10:0011:0012:0013:0014:0015:0016:00Prev. Close
9.160
All charts use the last traded price or closing price.

COMPANY PROFILE

Cutia Therapeutics is an investment holding company principally engaged in the dermatology biopharmaceutical business. The Company is dedicated to developing solutions in the dermatology treatment and care market, including scalp diseases and care, skin diseases and care, topical anesthesia and localized adipose accumulation management. The Company is primarily engaged in the distribution of scalp diseases and care products, as well as certain skin care products. The Company's principal pipeline products include topical finasteride spray CU-40102, topical 4% minocycline foam CU-10201, topical novel small molecule agent CU-10101, localized topical lidocaine and tetracaine cream CU-30101 and recombinant mutant collagenase CU-20401. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares) 319,466,511 (as at 30 Jun 2025)
Industry Healthcare - Pharmaceuticals & Biotechnology - Biotechnology Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Listing Date 12 Jun 2023
Financial Year Ends 31 Dec 2024
Chairman Chen Lian Yong
Principal Office Room 1919, 19/F
Lee Garden One
33 Hysan Avenue
Causeway Bay, Hong Kong
Place of Incorporation Cayman Islands
Listing Category Primary Listing

a. Updating time-lag
The number of issued shares / issued units presented is generally updated within 7 days after the Monthly Returns and Next Day Disclosure Returns published by the listed issuers on the HKEXnews website. Hence, the information presented here may not be the most up-to-date information submitted by the listed issuers as required under the Listing Rules.
b. Rights issues or bonus issues
The number of issued shares / issued units presented here will be adjusted with effect from the ex-date in the event of announced rights issues or announced bonus issues. In this case, both the number of issued shares / issued units before and after the adjustment will be presented.
c. Share splits or share consolidations
The number of issued shares / issued units presented here will be adjusted on the effective date in the event of share splits or share consolidations.
d. Conversion of convertible notes into shares
If the change of the number of issued shares / issued units is due to conversion of convertible bonds, the number of issued shares / issued units presented here may be updated based on the related company announcement.
Updated: 24 Jul 2025 09:36 HKT
* Company profile is provided by Refinitiv.

ENTITLEMENT

Date Announced Ex-Date Details Financial Year End Book Close Date Payment date may be indicative only.Payment Date
24 Mar 2025-No Dividend for the period ended
2024/12/31
31 Dec 2024--
29 Aug 2024-No Dividend for the period ended
2024/06/30
31 Dec 2024--
27 Mar 2024-No Dividend for the period ended
2023/12/31
31 Dec 2023--
29 Aug 2023-No Dividend for the period ended
2023/06/30
31 Dec 2023--
Updated: 24 Jul 2025 01:15 HKT
Dividend details are sourced from Announcement Forms published on HKEXnews